Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Merck's $70 Billion Investment
Published 6 months, 4 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover Merck’s $70 billion expansion of U.S. operations, the FDA’s latest approvals for Novo Nordisk’s Rybelsus and Roche’s Gazyva, and a new digital health partnership between Amazon and WeightWatchers bringing prescription weight-loss drugs directly to consumers.